logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Predictive value of C-reactive protein for tuberculosis, bloodstream infection or death among HIV-infected individuals with chronic, non-specific symptoms and negative sputum smear microscopy

Bedell RA, van Lettow M, Meaney C, Corbett EL, Chan AK,  et al.
2017-12-15 • Tropical Medicine and International Health
2017-12-15 • Tropical Medicine and International Health
BACKGROUND:
C-reactive protein (CRP) is an inflammatory biomarker that may identify patients at risk of infections or death. Mortality among HIV-infected persons commencing antiretr...
Conference Material
|
Poster

Identifying critically ill children at risk of dying during hospital admission in Malawi: prognostic accuracy of a modified qSOFA score

Kumwenda M, Assies R, Snik I, Chathima G, Langton J,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
Journal Article
|
Research

The second sputum sample complicates tuberculosis diagnosis for women: a qualitative study from Malawi

Kumwenda M, Nyang'wa BT, Chikuse B, Biseck T, Maosa S,  et al.
2017-12-01 • International Journal of Tuberculosis and Lung Disease
2017-12-01 • International Journal of Tuberculosis and Lung Disease
SETTING: District hospital and peripheral health care facilities in Balaka District, Malawi.OBJECTIVE: To identify barriers encountered by women in submitting a second sputum sam...
Journal Article
|
Research

High Prevalence of Tuberculosis and Serious Bloodstream Infections in Ambulatory Individuals Presenting for Antiretroviral Therapy in Malawi

Bedell RA, Anderson ST, van Lettow M, Akesson A, Corbett EL,  et al.
2012-06-22 • PLOS One
2012-06-22 • PLOS One
Background Tuberculosis (TB) and serious bloodstream infections (BSI) may contribute to the high early mortality observed among patients qualifying for antiretroviral therapy (ART) with ...